ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) |
Grant Type |
Year | State |
|---|---|---|---|---|
| Engager T cells for the Adoptive Immunotherapy of Pediatric Malignancies | Baylor College of Medicine / Stephen Gottschalk, MD | Innovation Grants | 2013 | Texas |
| Novel Targeted Therapies for Rhabdomyosarcoma | St. Jude Children’s Research Hospital / Michael Dyer, PhD | Innovation Grants | 2013 | Tennessee |
| Therapeutic Potential of the MST1/Hippo Tumor Suppressor Pathway in Alveolar Rhabdomyosarcoma | Duke University / Corinne Mary Linardic, MD, PhD | Innovation Grants | 2013 | North Carolina |
| Next-Generation Therapies for Hedgehog Pathway-Dependent Tumors | Lucile Packard Children’s Hospital at Stanford University School of Medicine / James Chen, PhD | Innovation Grants | 2013 | California |
| Mechanisms Regulating Medulloblastoma Progression | University of Pennsylvania / Nadia Dahmane, PhD | Innovation Grants | 2013 | Pennsylvania |
| Therapeutic Targeting of LARG-RhoA Signaling Axis in Childhood Leukemia | Cincinnati Children's Hospital Medical Center / Yi Zheng, PhD | Innovation Grants | 2013 | Ohio |
| Multispecific T Cells for Adoptive Immunotherapy of Pediatric High Grade Glioma (HGG) | Baylor College of Medicine / Nabil Ahmed, MD, MSc | Innovation Grants | 2013 | Texas |
| Genetic Alterations in Intramedullary Spinal Cord Tumors | The Johns Hopkins University School of Medicine / George Jallo, MD | Innovation Grants | 2013 | Maryland |
| Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma | Columbia University Medical Center / Darrell Yamashiro, MD, PhD | Innovation Grants | 2013 | New York |
| Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers | Dana-Farber Cancer Institute / Charles Roberts, MD, PhD | Innovation Grants | 2013 | Massachusetts |